Garlikov Julie Insider Trades

Insider Trading History

Track insider trading activity for Garlikov Julie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $44.1k 30,000 shares
Last Trade
May 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 30,000 shares
$4.93
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $1.26k 858 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.4k 858 shares
$23.80
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $1.26k 858 shares
Last Trade
May 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30k 858 shares
$34.99
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $0 0 shares
Last Trade
May 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30k 858 shares
$34.99
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $44.1k 30,000 shares
Last Trade
May 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.73M 30,000 shares
$224.18
$1.47
NewAge
NewAge NBEV
Chief Marketing Officer
Holding Value $4.68k 50,000 shares
Last Trade
Dec 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$91.5k 50,000 shares
$1.83
$0.09
NewAge
NewAge NBEV
Chief Marketing Officer
Holding Value $6.98k 74,627 shares
Last Trade
Nov 04, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$196k 74,627 shares
$2.63
$0.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up